BCYC
Bicycle Therapeutics plc$4.67-0.09 (-1.89%)Prev Close$4.77·MCap$372.8M·P/E—·Vol255.9K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
19
$482.9K
◆
Net Activity
Net Seller
$482.9K
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Bicycle Therapeutics plc (BCYC) has been exclusively selling, with 0 insider purchases totaling $0.00 and 19 insider sales totaling $482.9K. The most recent insider transaction was by Hannay Michael Charles Ferguson (CHIEF PROD & SUPPLY CHAIN OFF), who sold $34.5K worth of shares on Jan 2, 2026. Bicycle Therapeutics plc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $372.8M.
BCYC Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 5,194 | $6.64 | $34.5K | 0 |
| Jan 2, 2026 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 21,314 | $6.62 | $141.2K | 0 |
| Jan 2, 2026 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 6,660 | $6.63 | $44.1K | 0 |
| Jan 2, 2026 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 6,311 | $6.62 | $41.8K | 0 |
| Jan 2, 2026 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 2,432 | $6.64 | $16.1K | 0 |
| Jan 2, 2026 | Young Alethia | Chief Financial Officer | Sell | 7,623 | $6.62 | $50.5K | 0 |
| Oct 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 723 | $8.40 | $6.1K | 0 |
| Oct 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 5,494 | $8.41 | $46.2K | 0 |
| Oct 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 1,147 | $8.40 | $9.6K | 0 |
| Oct 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 1,802 | $8.41 | $15.1K | 0 |
| Oct 2, 2025 | Swanton Robert Charles | Director | Sell | 102 | $8.55 | $872.10 | 0 |
| Oct 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 324 | $8.40 | $2.7K | 0 |
| Oct 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 482 | $8.51 | $4.1K | 0 |
| Jul 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 722 | $7.21 | $5.2K | 0 |
| Jul 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 5,461 | $7.29 | $39.8K | 0 |
| Jul 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 1,149 | $7.09 | $8.1K | 0 |
| Jul 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 1,791 | $7.28 | $13.0K | 0 |
| Jul 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 306 | $7.20 | $2.2K | 0 |
| Jul 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 204 | $7.09 | $1.4K | 0 |
| Apr 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 733 | $7.82 | $5.7K | 0 |
| Apr 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 5,669 | $7.69 | $43.6K | 0 |
| Apr 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 1,133 | $8.02 | $9.1K | 0 |
| Apr 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 1,852 | $7.72 | $14.3K | 0 |
| Apr 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 319 | $7.84 | $2.5K | 0 |
| Apr 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 215 | $8.02 | $1.7K | 0 |
| Jan 2, 2025 | Arroyo Santiago | CHIEF DEVELOPMENT OFFICER | Sell | 4,943 | $14.09 | $69.6K | 0 |
| Jan 2, 2025 | Crockett Nigel | CHIEF BUSINESS OFFICER | Sell | 3,519 | $14.27 | $50.2K | 0 |
| Jan 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 2,118 | $14.16 | $30.0K | 0 |
| Jan 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 12,130 | $14.26 | $173.0K | 0 |
| Jan 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 4,578 | $14.09 | $64.5K | 0 |
| Jan 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 3,287 | $14.09 | $46.3K | 0 |
| Jan 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 4,595 | $14.64 | $67.3K | 0 |
| Jan 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 1,395 | $14.09 | $19.7K | 0 |
| Nov 11, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 6,256 | $25.11 | $157.1K | 0 |
| Oct 3, 2024 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 247 | $22.26 | $5.5K | 0 |
| Oct 3, 2024 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 3,212 | $22.26 | $71.5K | 0 |
| Oct 3, 2024 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 972 | $22.26 | $21.6K | 0 |
| Oct 3, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 153 | $22.26 | $3.4K | 0 |
| Jul 3, 2024 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 246 | $19.64 | $4.8K | 0 |
| Jul 3, 2024 | Keen Nicholas | CHIEF SCIENTIFIC OFFICER | Sell | 779 | $19.64 | $15.3K | 0 |
| Jul 3, 2024 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 3,194 | $19.64 | $62.7K | 0 |
| Jul 3, 2024 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 967 | $19.64 | $19.0K | 0 |
| Jul 3, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 148 | $19.64 | $2.9K | 0 |
| Apr 11, 2024 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 257 | $22.49 | $5.8K | 0 |
| Apr 3, 2024 | Keen Nicholas | CHIEF SCIENTIFIC OFFICER | Sell | 790 | $23.81 | $18.8K | 0 |
| Apr 3, 2024 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 3,158 | $23.81 | $75.2K | 0 |
| Apr 3, 2024 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 955 | $23.81 | $22.7K | 0 |
| Apr 3, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 152 | $23.81 | $3.6K | 0 |
| Jan 2, 2024 | Crockett Nigel | Chief Business Officer | Sell | 2,643 | $17.50 | $46.3K | 0 |
| Jan 2, 2024 | Keen Nicholas | Chief Scientific Officer | Sell | 2,640 | $17.50 | $46.2K | 0 |
Showing 1–50 of 96
1 / 2
BCYC Insider Buying Activity
The following table shows recent insider purchases of Bicycle Therapeutics plc (BCYC) stock reported via SEC Form 4 filings.
No insider buying activity found for BCYC in the last 12 months.
BCYC Insider Selling Activity
The following table shows recent insider sales of Bicycle Therapeutics plc (BCYC) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 5,194 | $6.64 | $34.5K | 0 |
| Jan 2, 2026 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 21,314 | $6.62 | $141.2K | 0 |
| Jan 2, 2026 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 6,660 | $6.63 | $44.1K | 0 |
| Jan 2, 2026 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 6,311 | $6.62 | $41.8K | 0 |
| Jan 2, 2026 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 2,432 | $6.64 | $16.1K | 0 |
| Jan 2, 2026 | Young Alethia | Chief Financial Officer | Sell | 7,623 | $6.62 | $50.5K | 0 |
| Oct 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 723 | $8.40 | $6.1K | 0 |
| Oct 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 5,494 | $8.41 | $46.2K | 0 |
| Oct 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 1,147 | $8.40 | $9.6K | 0 |
| Oct 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 1,802 | $8.41 | $15.1K | 0 |
| Oct 2, 2025 | Swanton Robert Charles | Director | Sell | 102 | $8.55 | $872.10 | 0 |
| Oct 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 324 | $8.40 | $2.7K | 0 |
| Oct 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 482 | $8.51 | $4.1K | 0 |
| Jul 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 722 | $7.21 | $5.2K | 0 |
| Jul 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 5,461 | $7.29 | $39.8K | 0 |
| Jul 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 1,149 | $7.09 | $8.1K | 0 |
| Jul 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 1,791 | $7.28 | $13.0K | 0 |
| Jul 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 306 | $7.20 | $2.2K | 0 |
| Jul 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 204 | $7.09 | $1.4K | 0 |
| Apr 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 733 | $7.82 | $5.7K | 0 |
| Apr 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 5,669 | $7.69 | $43.6K | 0 |
| Apr 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 1,133 | $8.02 | $9.1K | 0 |
| Apr 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 1,852 | $7.72 | $14.3K | 0 |
| Apr 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 319 | $7.84 | $2.5K | 0 |
| Apr 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 215 | $8.02 | $1.7K | 0 |
| Jan 2, 2025 | Arroyo Santiago | CHIEF DEVELOPMENT OFFICER | Sell | 4,943 | $14.09 | $69.6K | 0 |
| Jan 2, 2025 | Crockett Nigel | CHIEF BUSINESS OFFICER | Sell | 3,519 | $14.27 | $50.2K | 0 |
| Jan 2, 2025 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 2,118 | $14.16 | $30.0K | 0 |
| Jan 2, 2025 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 12,130 | $14.26 | $173.0K | 0 |
| Jan 2, 2025 | Milnes Alistair | CHIEF OPERATING OFFICER | Sell | 4,578 | $14.09 | $64.5K | 0 |
| Jan 2, 2025 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 3,287 | $14.09 | $46.3K | 0 |
| Jan 2, 2025 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 4,595 | $14.64 | $67.3K | 0 |
| Jan 2, 2025 | Young Alethia | Chief Financial Officer | Sell | 1,395 | $14.09 | $19.7K | 0 |
| Nov 11, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 6,256 | $25.11 | $157.1K | 0 |
| Oct 3, 2024 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 247 | $22.26 | $5.5K | 0 |
| Oct 3, 2024 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 3,212 | $22.26 | $71.5K | 0 |
| Oct 3, 2024 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 972 | $22.26 | $21.6K | 0 |
| Oct 3, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 153 | $22.26 | $3.4K | 0 |
| Jul 3, 2024 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 246 | $19.64 | $4.8K | 0 |
| Jul 3, 2024 | Keen Nicholas | CHIEF SCIENTIFIC OFFICER | Sell | 779 | $19.64 | $15.3K | 0 |
| Jul 3, 2024 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 3,194 | $19.64 | $62.7K | 0 |
| Jul 3, 2024 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 967 | $19.64 | $19.0K | 0 |
| Jul 3, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 148 | $19.64 | $2.9K | 0 |
| Apr 11, 2024 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 257 | $22.49 | $5.8K | 0 |
| Apr 3, 2024 | Keen Nicholas | CHIEF SCIENTIFIC OFFICER | Sell | 790 | $23.81 | $18.8K | 0 |
| Apr 3, 2024 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 3,158 | $23.81 | $75.2K | 0 |
| Apr 3, 2024 | Skynner Michael | CHIEF TECHNOLOGY OFFICER | Sell | 955 | $23.81 | $22.7K | 0 |
| Apr 3, 2024 | Thompson Travis Alvin | CHIEF ACCOUNTING OFFICER | Sell | 152 | $23.81 | $3.6K | 0 |
| Jan 2, 2024 | Crockett Nigel | Chief Business Officer | Sell | 2,643 | $17.50 | $46.3K | 0 |
| Jan 2, 2024 | Keen Nicholas | Chief Scientific Officer | Sell | 2,640 | $17.50 | $46.2K | 0 |
BCYC Insiders
Similar Stocks to BCYC
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B